Pulmonology Lasers Market Report 2024

The pulmonology lasers market size has grown strongly in recent years. It will grow from $4.62 billion in 2023 to $5.06 billion in 2024 at a compound annual growth rate (CAGR) of 9.4%. The growth observed in the historic period can be attributed to several factors include the introduction and adoption of laser technology in pulmonology, initial applications of lasers in respiratory medicine, advancements in delivery systems, and the development of techniques such as laser bronchoscopy.

The pulmonology lasers market size is expected to see strong growth in the next few years. It will grow to $7.31 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The increase projected for the forecast period stems from improvements in clinical efficacy, advancements in miniaturizing laser technology, enhanced training and education, streamlined regulatory processes and approvals, and a growing patient preference for minimally invasive procedures. Key trends anticipated during this period encompass precision medicine, considerations of cost and accessibility, ongoing research into immunotherapy and combination therapies, regulatory and ethical challenges, and the expansion of minimally invasive treatment options.

The anticipated increase in chronic respiratory diseases is expected to drive growth in the pulmonology laser market moving forward. Chronic respiratory diseases encompass long-term conditions affecting the airways and lung structures, resulting in breathing difficulties and significantly impacting quality of life. Factors contributing to the rise in these diseases include air pollution, smoking, an aging population, rapid urbanization, and climate changes. Pulmonology lasers play a crucial role in the diagnosis and treatment of chronic respiratory diseases through procedures such as diagnostic bronchoscopy and therapeutic interventions such as addressing airway obstructions or tumors. For example, as of June 2024, the Australian Institute of Health and Welfare reported that approximately 2.8 million Australians, accounting for 11% of the population, were estimated to have asthma, a common chronic respiratory condition. Additionally, about 638,000 individuals, or 2.5% of the population, were living with chronic obstructive pulmonary disease (COPD), a condition that contributed significantly to mortality rates in Australia, constituting 4% of deaths that year. Thus, the increasing prevalence of chronic respiratory diseases underscores their role in propelling growth within the pulmonology laser market.

Major companies in the pulmonology laser market are concentrating on advancing technology, such as next-generation integrated laser technology, to enhance both diagnostic accuracy and therapeutic precision. Next-generation integrated laser technology refers to advanced systems that integrate laser devices with sophisticated software and hardware innovations, aimed at improving precision, efficiency, and therapeutic capabilities in medical applications. For instance, in September 2022, Lumibird Medical, a French company specializing in ophthalmic and medical equipment, introduced the Capsulo Nd, YAG laser. This innovative device incorporates advanced Nd laser technology and precision engineering to provide medical professionals with enhanced precision, safety, and efficiency during various medical procedures. Designed for versatility, it ensures precise tissue interaction while minimizing thermal damage, setting a new standard in laser technology for superior performance and better patient outcomes.

In September 2021, Boston Scientific Corporation, a US-based medical device manufacturer, completed the acquisition of Lumenis Ltd.'s surgical business for $1.07 billion. This strategic move enables Boston Scientific to integrate Lumenis' laser portfolio, which includes their advanced MOSES technology, with Boston Scientific's leading products in kidney stone management and benign prostatic hyperplasia treatments. Lumenis Ltd., based in Israel, specializes in manufacturing pulmonology lasers among other medical devices.

Major companies operating in the pulmonology lasers market are Cynosure Inc., Coherent Corp., Han's Laser Technology Industry Group, IPG Photonics Corporation, HÜBNER Photonics, Lumenis Ltd, Cutera Inc., Lumibird SA, Candela Corporation, Fotona LLC, Sciton Inc., Ellex Medical Pty Ltd, Spectra-Physics Inc., EKSPLA Co, Biolitec AG, Hironic Inc., Alma Lasers Ltd., Bestview Company, Photomedex Inc., Optotek Medical, Optogama UAB, Beijing Hoplaser Lead-Edge Laser Techno. Ltd, Beijing Sincoheren S & T Development Co Ltd, Fisioline Srl, Amada Miyachi.

North America was the largest region in the pulmonology lasers market in 2023. The regions covered in the pulmonology lasers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pulmonology lasers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Pulmonology lasers are specialized medical devices utilized for both diagnostic and therapeutic purposes in the treatment of various respiratory conditions. These lasers emit high-energy light beams capable of precisely targeting and vaporizing abnormal or diseased tissue within the lungs. The aim of pulmonology lasers is to offer minimally invasive treatment options for respiratory diseases, thereby reducing the reliance on traditional surgery and improving patient outcomes.

The primary types of pulmonology lasers include neodymium-doped yttrium aluminum garnet (Nd-YAG) and photodynamic lasers. Nd-YAG lasers utilize a crystal that emits powerful infrared light, commonly employed in treating conditions such as bronchogenic carcinoma, malignant lesions, benign tumors, neoplasms, hemorrhage, and tracheal stenosis. End users of pulmonology lasers encompass specialty care centers, hospitals, academic institutions, and research organizations.

The pulmonology laser research report is one of a series of new reports that provides pulmonology laser market statistics, including the pulmonology laser industry's global market size, regional shares, competitors with a pulmonology laser market share, detailed pulmonology laser market segments, market trends and opportunities, and any further data you may need to thrive in the pulmonology laser industry. This pulmonology laser market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pulmonology lasers market consists of sales of laser systems, laser fibers and probes, protective eyewear, smoke evacuators, and disposable components. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.